The following is a summary of "Early prediction of progression-free survival of patients with locally advanced nasopharyngeal ...

Adjuvant therapy with camrelizumab significantly improved 3-year event-free survival in patients with locoregionally advanced nasopharyngeal carcinoma compared with observation, according to ...

Deborah Wong, MD, PhD, discusses the toripalimab combination that is now considered standard of care in nasopharyngeal cancer ...

A Hong Kong research team has developed a new screening method that detects the DNA of a virus associated with nasopharyngeal cancer in blood, enabling the early identification of high-risk ...

Professor Chen Xiaozhong, one of the principal investigators of penpulimab at Zhejiang Cancer Hospital, said: "Nasopharyngeal cancer (NPC) is a highly prevalent malignancy in certain regions ...